Sarcolemmal Ca2+-entry through L-type Ca2+ channels controls the profile of Ca2+-activated Cl- current in canine ventricular myocytes

Balázs Horváth, Krisztina Váczi, Bence Hegyi, M. Gönczi, Beatrix Dienes, Kornél Kistamás, Tamás Bányász, J. Magyar, I. Baczkó, A. Varró, György Seprényi, L. Csernoch, P. Nánási, N. Szentandrássy

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Ca2+-activated Cl- current (ICl(Ca)) mediated by TMEM16A and/or Bestrophin-3 may contribute to cardiac arrhythmias. The true profile of ICl(Ca) during an actual ventricular action potential (AP), however, is poorly understood. We aimed to study the profile of ICl(Ca) systematically under physiological conditions (normal Ca2+ cycling and AP voltage-clamp) as well as in conditions designed to change [Ca2+]i. The expression of TMEM16A and/or Bestrophin-3 in canine and human left ventricular myocytes was examined. The possible spatial distribution of these proteins and their co-localization with Cav1.2 was also studied. The profile of ICl(Ca), identified as a 9-anthracene carboxylic acid-sensitive current under AP voltage-clamp conditions, contained an early fast outward and a late inward component, overlapping early and terminal repolarizations, respectively. Both components were moderately reduced by ryanodine, while fully abolished by BAPTA, but not EGTA. [Ca2+]i was monitored using Fura-2-AM. Setting [Ca2+]i to the systolic level measured in the bulk cytoplasm (1.1 μM) decreased ICl(Ca), while application of Bay K8644, isoproterenol, and faster stimulation rates increased the amplitude of ICl(Ca). Ca2+-entry through L-type Ca2+ channels was essential for activation of ICl(Ca). TMEM16A and Bestrophin-3 showed strong co-localization with one another and also with Cav1.2 channels, when assessed using immunolabeling and confocal microscopy in both canine myocytes and human ventricular myocardium. Activation of ICl(Ca) in canine ventricular cells requires Ca2+-entry through neighboring L-type Ca2+ channels and is only augmented by SR Ca2+-release. Substantial activation of ICl(Ca) requires high Ca2+ concentration in the dyadic clefts which can be effectively buffered by BAPTA, but not EGTA.

Original languageEnglish
Pages (from-to)125-139
Number of pages15
JournalJournal of Molecular and Cellular Cardiology
Volume97
DOIs
Publication statusPublished - Aug 1 2016

Fingerprint

Muscle Cells
Action Potentials
Canidae
Egtazic Acid
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
Ryanodine
Fura-2
Isoproterenol
Confocal Microscopy
Cardiac Arrhythmias
Myocardium
Cytoplasm
Proteins
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
9-anthroic acid

Keywords

  • Action potential voltage-clamp
  • Bestrophin-3
  • Ca-activated Cl current
  • Canine cardiomyocytes
  • Human cardiomyocytes
  • TMEM16A

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Sarcolemmal Ca2+-entry through L-type Ca2+ channels controls the profile of Ca2+-activated Cl- current in canine ventricular myocytes. / Horváth, Balázs; Váczi, Krisztina; Hegyi, Bence; Gönczi, M.; Dienes, Beatrix; Kistamás, Kornél; Bányász, Tamás; Magyar, J.; Baczkó, I.; Varró, A.; Seprényi, György; Csernoch, L.; Nánási, P.; Szentandrássy, N.

In: Journal of Molecular and Cellular Cardiology, Vol. 97, 01.08.2016, p. 125-139.

Research output: Contribution to journalArticle

@article{6b8dc3324cf54dd7a39e2e76f4e070b9,
title = "Sarcolemmal Ca2+-entry through L-type Ca2+ channels controls the profile of Ca2+-activated Cl- current in canine ventricular myocytes",
abstract = "Ca2+-activated Cl- current (ICl(Ca)) mediated by TMEM16A and/or Bestrophin-3 may contribute to cardiac arrhythmias. The true profile of ICl(Ca) during an actual ventricular action potential (AP), however, is poorly understood. We aimed to study the profile of ICl(Ca) systematically under physiological conditions (normal Ca2+ cycling and AP voltage-clamp) as well as in conditions designed to change [Ca2+]i. The expression of TMEM16A and/or Bestrophin-3 in canine and human left ventricular myocytes was examined. The possible spatial distribution of these proteins and their co-localization with Cav1.2 was also studied. The profile of ICl(Ca), identified as a 9-anthracene carboxylic acid-sensitive current under AP voltage-clamp conditions, contained an early fast outward and a late inward component, overlapping early and terminal repolarizations, respectively. Both components were moderately reduced by ryanodine, while fully abolished by BAPTA, but not EGTA. [Ca2+]i was monitored using Fura-2-AM. Setting [Ca2+]i to the systolic level measured in the bulk cytoplasm (1.1 μM) decreased ICl(Ca), while application of Bay K8644, isoproterenol, and faster stimulation rates increased the amplitude of ICl(Ca). Ca2+-entry through L-type Ca2+ channels was essential for activation of ICl(Ca). TMEM16A and Bestrophin-3 showed strong co-localization with one another and also with Cav1.2 channels, when assessed using immunolabeling and confocal microscopy in both canine myocytes and human ventricular myocardium. Activation of ICl(Ca) in canine ventricular cells requires Ca2+-entry through neighboring L-type Ca2+ channels and is only augmented by SR Ca2+-release. Substantial activation of ICl(Ca) requires high Ca2+ concentration in the dyadic clefts which can be effectively buffered by BAPTA, but not EGTA.",
keywords = "Action potential voltage-clamp, Bestrophin-3, Ca-activated Cl current, Canine cardiomyocytes, Human cardiomyocytes, TMEM16A",
author = "Bal{\'a}zs Horv{\'a}th and Krisztina V{\'a}czi and Bence Hegyi and M. G{\"o}nczi and Beatrix Dienes and Korn{\'e}l Kistam{\'a}s and Tam{\'a}s B{\'a}ny{\'a}sz and J. Magyar and I. Baczk{\'o} and A. Varr{\'o} and Gy{\"o}rgy Sepr{\'e}nyi and L. Csernoch and P. N{\'a}n{\'a}si and N. Szentandr{\'a}ssy",
year = "2016",
month = "8",
day = "1",
doi = "10.1016/j.yjmcc.2016.05.006",
language = "English",
volume = "97",
pages = "125--139",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Sarcolemmal Ca2+-entry through L-type Ca2+ channels controls the profile of Ca2+-activated Cl- current in canine ventricular myocytes

AU - Horváth, Balázs

AU - Váczi, Krisztina

AU - Hegyi, Bence

AU - Gönczi, M.

AU - Dienes, Beatrix

AU - Kistamás, Kornél

AU - Bányász, Tamás

AU - Magyar, J.

AU - Baczkó, I.

AU - Varró, A.

AU - Seprényi, György

AU - Csernoch, L.

AU - Nánási, P.

AU - Szentandrássy, N.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Ca2+-activated Cl- current (ICl(Ca)) mediated by TMEM16A and/or Bestrophin-3 may contribute to cardiac arrhythmias. The true profile of ICl(Ca) during an actual ventricular action potential (AP), however, is poorly understood. We aimed to study the profile of ICl(Ca) systematically under physiological conditions (normal Ca2+ cycling and AP voltage-clamp) as well as in conditions designed to change [Ca2+]i. The expression of TMEM16A and/or Bestrophin-3 in canine and human left ventricular myocytes was examined. The possible spatial distribution of these proteins and their co-localization with Cav1.2 was also studied. The profile of ICl(Ca), identified as a 9-anthracene carboxylic acid-sensitive current under AP voltage-clamp conditions, contained an early fast outward and a late inward component, overlapping early and terminal repolarizations, respectively. Both components were moderately reduced by ryanodine, while fully abolished by BAPTA, but not EGTA. [Ca2+]i was monitored using Fura-2-AM. Setting [Ca2+]i to the systolic level measured in the bulk cytoplasm (1.1 μM) decreased ICl(Ca), while application of Bay K8644, isoproterenol, and faster stimulation rates increased the amplitude of ICl(Ca). Ca2+-entry through L-type Ca2+ channels was essential for activation of ICl(Ca). TMEM16A and Bestrophin-3 showed strong co-localization with one another and also with Cav1.2 channels, when assessed using immunolabeling and confocal microscopy in both canine myocytes and human ventricular myocardium. Activation of ICl(Ca) in canine ventricular cells requires Ca2+-entry through neighboring L-type Ca2+ channels and is only augmented by SR Ca2+-release. Substantial activation of ICl(Ca) requires high Ca2+ concentration in the dyadic clefts which can be effectively buffered by BAPTA, but not EGTA.

AB - Ca2+-activated Cl- current (ICl(Ca)) mediated by TMEM16A and/or Bestrophin-3 may contribute to cardiac arrhythmias. The true profile of ICl(Ca) during an actual ventricular action potential (AP), however, is poorly understood. We aimed to study the profile of ICl(Ca) systematically under physiological conditions (normal Ca2+ cycling and AP voltage-clamp) as well as in conditions designed to change [Ca2+]i. The expression of TMEM16A and/or Bestrophin-3 in canine and human left ventricular myocytes was examined. The possible spatial distribution of these proteins and their co-localization with Cav1.2 was also studied. The profile of ICl(Ca), identified as a 9-anthracene carboxylic acid-sensitive current under AP voltage-clamp conditions, contained an early fast outward and a late inward component, overlapping early and terminal repolarizations, respectively. Both components were moderately reduced by ryanodine, while fully abolished by BAPTA, but not EGTA. [Ca2+]i was monitored using Fura-2-AM. Setting [Ca2+]i to the systolic level measured in the bulk cytoplasm (1.1 μM) decreased ICl(Ca), while application of Bay K8644, isoproterenol, and faster stimulation rates increased the amplitude of ICl(Ca). Ca2+-entry through L-type Ca2+ channels was essential for activation of ICl(Ca). TMEM16A and Bestrophin-3 showed strong co-localization with one another and also with Cav1.2 channels, when assessed using immunolabeling and confocal microscopy in both canine myocytes and human ventricular myocardium. Activation of ICl(Ca) in canine ventricular cells requires Ca2+-entry through neighboring L-type Ca2+ channels and is only augmented by SR Ca2+-release. Substantial activation of ICl(Ca) requires high Ca2+ concentration in the dyadic clefts which can be effectively buffered by BAPTA, but not EGTA.

KW - Action potential voltage-clamp

KW - Bestrophin-3

KW - Ca-activated Cl current

KW - Canine cardiomyocytes

KW - Human cardiomyocytes

KW - TMEM16A

UR - http://www.scopus.com/inward/record.url?scp=84969592912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969592912&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2016.05.006

DO - 10.1016/j.yjmcc.2016.05.006

M3 - Article

VL - 97

SP - 125

EP - 139

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

ER -